Recruiting HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921 Conditions Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +63 more Locations Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington, United States View Trial Details
Recruiting Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810 Conditions Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more Locations Mayo Clinic in Arizona — Scottsdale, Arizona, United States Mayo Clinic in Rochester — Rochester, Minnesota, United States View Trial Details
Completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies NCT04681105 Conditions Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Burkitt Lymphoma, +58 more Locations City of Hope Medical Center — Duarte, California, United States View Trial Details
